Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.

New biomedical prevention technologies (NPTs) may contribute to substantially reducing incident HIV infections globally. We explored acceptability and preferences for NPTs among key and other vulnerable populations in two South African townships.We conducted six focus groups and 12 in-depth intervie...

Full description

Bibliographic Details
Main Authors: Millicent Atujuna, Peter A Newman, Melissa Wallace, Megan Eluhu, Clara Rubincam, Ben Brown, Linda-Gail Bekker
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5805172?pdf=render
id doaj-e944b4383ab44dc88dfa47ff1737d6d5
record_format Article
spelling doaj-e944b4383ab44dc88dfa47ff1737d6d52020-11-24T22:17:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01132e019125110.1371/journal.pone.0191251Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.Millicent AtujunaPeter A NewmanMelissa WallaceMegan EluhuClara RubincamBen BrownLinda-Gail BekkerNew biomedical prevention technologies (NPTs) may contribute to substantially reducing incident HIV infections globally. We explored acceptability and preferences for NPTs among key and other vulnerable populations in two South African townships.We conducted six focus groups and 12 in-depth interviews with adolescents, and adult heterosexual men, women, and men who have sex with men (MSM) (n = 48), and eight in-depth interviews with key informant healthcare workers. The interview guide described pre-exposure prophylaxis (PrEP), vaginal rings, rectal microbicides and HIV vaccines, and explored acceptability and product preferences. Focus groups and in-depth interviews (45-80 minutes) were conducted in Xhosa, audiotaped, and transcribed and translated into English. Data were coded and reviewed using framework analysis with NVivo software.Overall, initial enthusiasm and willingness to use NPTs evolved into concerns about how particular NPTs might affect or require alterations in one's everyday lifestyle and practices. Different product preferences and motivations emerged by population based on similarity to existing practices and contexts of vulnerability. Adult women and female adolescents preferred a vaginal ring and HIV vaccine, motivated by longer duration of protection to mitigate feared repercussions from male partners, including threats to their marriage and safety, and a context of ubiquitous rape. Male adolescents preferred an HIV vaccine, seen as protection in serodiscordant relationships and convenient in obviating the HIV stigma and cost involved in buying condoms. Adult men preferred PrEP, given familiarity with oral medications and mistrust of injections, seen as enabling serodiscordant couples to have a child. MSM preferred a rectal microbicide given familiarity with gel-based lubricants, with concerns about duration of protection in the context of unplanned consensual sex and rape.Biomedical interventions to prevent HIV transmission, rather than obviating social-structural factors that produce vulnerability, may be limited by these same factors. Implementation of NPTs should engage local communities to understand real-world constraints and strategise to deliver effective, multi-level combination prevention.http://europepmc.org/articles/PMC5805172?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Millicent Atujuna
Peter A Newman
Melissa Wallace
Megan Eluhu
Clara Rubincam
Ben Brown
Linda-Gail Bekker
spellingShingle Millicent Atujuna
Peter A Newman
Melissa Wallace
Megan Eluhu
Clara Rubincam
Ben Brown
Linda-Gail Bekker
Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
PLoS ONE
author_facet Millicent Atujuna
Peter A Newman
Melissa Wallace
Megan Eluhu
Clara Rubincam
Ben Brown
Linda-Gail Bekker
author_sort Millicent Atujuna
title Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
title_short Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
title_full Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
title_fullStr Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
title_full_unstemmed Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.
title_sort contexts of vulnerability and the acceptability of new biomedical hiv prevention technologies among key populations in south africa: a qualitative study.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2018-01-01
description New biomedical prevention technologies (NPTs) may contribute to substantially reducing incident HIV infections globally. We explored acceptability and preferences for NPTs among key and other vulnerable populations in two South African townships.We conducted six focus groups and 12 in-depth interviews with adolescents, and adult heterosexual men, women, and men who have sex with men (MSM) (n = 48), and eight in-depth interviews with key informant healthcare workers. The interview guide described pre-exposure prophylaxis (PrEP), vaginal rings, rectal microbicides and HIV vaccines, and explored acceptability and product preferences. Focus groups and in-depth interviews (45-80 minutes) were conducted in Xhosa, audiotaped, and transcribed and translated into English. Data were coded and reviewed using framework analysis with NVivo software.Overall, initial enthusiasm and willingness to use NPTs evolved into concerns about how particular NPTs might affect or require alterations in one's everyday lifestyle and practices. Different product preferences and motivations emerged by population based on similarity to existing practices and contexts of vulnerability. Adult women and female adolescents preferred a vaginal ring and HIV vaccine, motivated by longer duration of protection to mitigate feared repercussions from male partners, including threats to their marriage and safety, and a context of ubiquitous rape. Male adolescents preferred an HIV vaccine, seen as protection in serodiscordant relationships and convenient in obviating the HIV stigma and cost involved in buying condoms. Adult men preferred PrEP, given familiarity with oral medications and mistrust of injections, seen as enabling serodiscordant couples to have a child. MSM preferred a rectal microbicide given familiarity with gel-based lubricants, with concerns about duration of protection in the context of unplanned consensual sex and rape.Biomedical interventions to prevent HIV transmission, rather than obviating social-structural factors that produce vulnerability, may be limited by these same factors. Implementation of NPTs should engage local communities to understand real-world constraints and strategise to deliver effective, multi-level combination prevention.
url http://europepmc.org/articles/PMC5805172?pdf=render
work_keys_str_mv AT millicentatujuna contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy
AT peteranewman contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy
AT melissawallace contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy
AT meganeluhu contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy
AT clararubincam contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy
AT benbrown contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy
AT lindagailbekker contextsofvulnerabilityandtheacceptabilityofnewbiomedicalhivpreventiontechnologiesamongkeypopulationsinsouthafricaaqualitativestudy
_version_ 1725785386584637440